WO2020042665A1 - Shark cartilage glycoprotein and anticancer use thereof - Google Patents

Shark cartilage glycoprotein and anticancer use thereof Download PDF

Info

Publication number
WO2020042665A1
WO2020042665A1 PCT/CN2019/086298 CN2019086298W WO2020042665A1 WO 2020042665 A1 WO2020042665 A1 WO 2020042665A1 CN 2019086298 W CN2019086298 W CN 2019086298W WO 2020042665 A1 WO2020042665 A1 WO 2020042665A1
Authority
WO
WIPO (PCT)
Prior art keywords
shark cartilage
pharmaceutical composition
grams
cancer
shell
Prior art date
Application number
PCT/CN2019/086298
Other languages
French (fr)
Chinese (zh)
Inventor
车路平
Original Assignee
车路平
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 车路平 filed Critical 车路平
Publication of WO2020042665A1 publication Critical patent/WO2020042665A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/58Reptiles
    • A61K35/586Turtles; Tortoises, e.g. terrapins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/78Saururaceae (Lizard's-tail family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/90Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Definitions

  • the invention belongs to the field of medicine, and particularly relates to a shark cartilage glycoprotein and its anticancer use.
  • Cancer also known as malignant tumor, refers to a class of diseases in which the uncontrolled proliferation of cells caused by the abnormal mechanism of control of cell proliferation and local invasion of surrounding normal tissues, or even metastasis to other parts of the body via the internal circulatory system or lymphatic system .
  • cancer has no obvious clinical symptoms in its early stages, it is often at the advanced stage of cancer when it is discovered, which often leads to the best treatment window missed at the time of discovery, making its mortality rate high and becoming one of the top five terminal illnesses in the world. China is one of the regions with high incidence of cancer. In recent years, the incidence of cancer is increasing year by year. In 2014, there were about 3.8 million new cancers and 2.29 million deaths. As of now, the exact pathogenesis of cancer is still unclear.
  • exogenous factors include lifestyle habits, environmental pollution, and iatrogenic factors.
  • Source factors include genetic factors, immune factors, and endocrine factors.
  • the treatment of cancer mainly includes surgical treatment, radiotherapy, chemotherapy, etc.
  • surgical treatment can theoretically completely remove cancer tissue, thereby achieving cure of cancer, but since cancer is mostly in advanced stage when cancer is discovered, cancer cells have invaded the surrounding normal. Tissue or spread to other organs of the body with the circulatory system, making it impossible to completely understand cancer cells through surgery, and surgery is an invasive treatment.
  • the destruction of the circulatory system surrounding cancer tissue may promote cancer cells to a certain extent
  • Radiation therapy is a method of using radiation to kill cancer cells.
  • Chemotherapy refers to taking drugs that kill cancer cells and is used to treat cancer. Chemotherapy drugs also have damage to normal cells, but through the continuous development of chemotherapeutic drugs, people are working hard to develop drugs with less effect on normal tissues through targeted administration to avoid the damage to normal tissue cells during chemotherapy. Damage, which can effectively treat cancer.
  • shark cartilage was found to have an effect of inhibiting angiogenesis, so it was gradually applied to the prevention and treatment of cancer, but its overall therapeutic effect was still not ideal.
  • people have studied the anti-cancer effects of shark cartilage extract, shark chondroitin, and shark cartilage angiogenesis inhibitors, and have not achieved breakthrough progress. Even the view that shark cartilage does not have anti-cancer effect has appeared.
  • the inventors of the present invention have isolated a shark cartilage glycoprotein from shark cartilage through a large number of experiments. Pharmacological experiments have shown that it has excellent inhibition of vascularization and The effect of promoting cancer cell apoptosis can be used for cancer prevention and treatment.
  • the object of the present invention is to provide a use of shark cartilage glycoprotein in preparing an anticancer medicine.
  • the shark cartilage glycoprotein is prepared by the following method:
  • the shark cartilage is crushed and passed through a 10-30 mesh sieve to obtain shark cartilage particles;
  • It is still another object of the present invention to provide an anticancer pharmaceutical composition comprising shark cartilage glycoprotein or shark cartilage.
  • the anti-cancer pharmaceutical composition further comprises turtle plate, abalone shell, baking soda, clam shell, purslane, beef bone meal, Poria cocos, Shanci mushroom, sage grass, Houttuynia cordata, astragalus, Qumai, zero Lingxiang.
  • the anti-cancer drug composition comprises 5-10 parts of shark cartilage, 2-5 parts of turtle plate, 1-3 parts of abalone shell, 1-3 parts of baking soda, 1-3 parts of clam shell, and purslane 3- 8 servings, 8-15 servings of beef bone powder, 2-5 servings of Poria cocos, 5-10 servings of Shan Ci mushrooms, 2-5 servings of Saguaris, 1-3 servings of Houttuynia cordata, 1-3 servings of Astragalus, 1 serving of Qumai Made from 3 servings and 1-3 tonka incense.
  • the anticancer drug composition is composed of 80 g of shark cartilage, 30 g of tortoise shell, 20 g of abalone shell, 20 g of baking soda, 20 g of clam shell, 50 g of purslane, 100 g of beef bone powder, and 30 g of Poria 30 It is made from 80 grams, 80 grams of Shanci mushroom, 30 grams of misograss, 10 grams of houttuynia, 10 grams of astragalus, 10 grams of qumai, and 10 grams of tonka.
  • Shark cartilage It has multiple functions such as anti-tumor, rheumatism, analgesia, and diarrhea. It is often used in the treatment of rheumatoid arthritis, headache, diarrhea and other symptoms.
  • Turtle plate It is the plastron and carapace of the tortoise chinemys reevesii, mainly distributed in Zhejiang, Hubei, Hunan and other places.
  • the turtle plate tastes salty, sweet, and has the effects of nourishing yin, Qianyang, kidney, and bones. It is often used in Bone steaming fever, hot flashes, night sweats, bleeding, nocturnal emission, seminal discharge, epiphysis, vomiting and other symptoms. Modern pharmacological studies have shown that turtle plate can improve the body's immune function and anti-tumor effects.
  • Abalone shell also known as stone cassia, it is a precious medicinal material, which has the functions of heat-clearing and liver-relieving, nourishing yin and aphrodisiac, abalone and abalone shell contain rich protein, and the abalone shell itself has very high nutritional value. Abalone shell can be treated with medicine. Chitin, which is extracted from abalone shells, can be used for the treatment of gastric, duodenal ulcers, and hyperacidity.
  • Baking soda Sodium bicarbonate, the chemical formula is NaHCO 3.
  • the baking soda solution is alkaline. It can be sterilized and disinfected externally in medicine. Oral can be used to treat hyperacidity. Intravenous administration can also be used to correct acidosis. Modern pathological studies show that the tumor has an acidic environment. Taking baking soda can break the acidic environment of tumor tissues and inhibit tumor cell proliferation.
  • Clam shells Clams are salty and cold, and they have the functions of nourishing yin, moisturizing, diuretic, swelling, soft and firm.
  • Clam shells are salty, cold, and can enter the lung, kidney, and liver meridians. They can clear heat, relieve phlegm, dampness, and softness. They are often used to treat stomach pain, cough, cough, edema, and urination. Bloated and scalded.
  • the well-known herbal clam powder is that the clam shells are washed and then charcoal fired and roasted for the treatment of phlegm, fire and cough.
  • Purslane It is the dry aerial part of purslane, purslane, sour, cold, returning to the liver, large intestine, and has the effects of clearing heat and dampness, detoxification and swelling, anti-inflammatory, thirst quenching, and diuretic. It is commonly used in Treatment of fever, blood poisoning, carbuncle, scabies, eczema, erysipelas, snake bite, blood in the stool, and leakage.
  • Bovine Bone Meal It is the bone of the bovine bison ox or buffalo buffalo. It is sweet and warm. It has the functions of paralysis, truncation, and astringent sores. It is often used for arthritis, diarrhea, malaria, scabies, etc. Treatment.
  • the bone marrow contained in the bone has been recorded since ancient times as “replenishing the essence, strengthening the bones, and prolonging life”.
  • the ancient book “Shou Shi Zhen Yuan” believes that the bone marrow "specially repairs damage, promotes blood circulation, strengthens the skin, rejuvenates the skin, and returns to the age of children", and is anti-aging Hematopoietic organs can enhance the body's hematopoietic function and improve the body's immunity.
  • Poria cocos It is a dry rhizome of Liliaceae, Phyllostachys pubescens, which is sweet, light and flat. It has the effects of detoxification and dehumidification, and the same joints. It is often used for the treatment of limb constriction caused by syphilis and mercury poisoning.
  • Shanci mushroom It is a dried pseudobulb of the orchid family Rhododendron Orchid, Orchid Orchid, or Yunnan Orchid Orchid. It is sweet, slightly spicy, cool, and belongs to the liver and spleen. It has the effect of clearing heat and detoxifying, eliminating spleen and dissolving stagnation, and is often used for the treatment of bloated and swollen venom, rickets, and snake bite.
  • Scaly grass The dried whole grass of Scalyaceae white flower Scaly sauce, tastes bitter, bitter, cool, and returns to the liver, stomach, and large intestine meridian. It has the functions of clearing heat and detoxifying, expectorant and purulent, and is often used in intestines and lungs. Treatment of dysentery, dysentery, swollen scabies.
  • Houttuynia cordata It is the dry aerial part of amaranthaceae plant Amaranth. It has the functions of clearing heat and detoxifying, reducing swelling and purging sore, diuretic and dehumidifying, clearing heat and stopping dysentery, strengthening stomach and digesting food, and can be used to treat lung pus ulcer, lung heat cough and asthma, fever, hot shower, edema, beriberi, urinary infection Excessive, swollen, sore, and so on. Modern pharmacological studies have shown that Houttuynia cordata also has antibacterial, antiviral, body immunity, and diuretic effects.
  • Houttuynia cordata has good effects on upper respiratory tract infections, bronchitis, pneumonia, chronic bronchitis, chronic cervicitis, and pertussis, and it also has certain effects on acute conjunctivitis and urinary tract infections.
  • Astragalus membranaceus Mongolian astragalus root is a legume, sweet and warm, and belongs to the lungs, spleen, liver and kidney. It has the effects of replenishing qi and solid surface, detoxifying and purging, diuretic, and muscle growth. It is often used for the treatment of qi deficiency and fatigue, chronic diarrhea and prolapse, spontaneous sweating, edema, uterine prolapse, diabetes, and long-term non-healing of wounds.
  • Qumai It is the dry aerial part of the Dianthus plant Qumai, which has bitter taste, coldness, homesickness, and small intestine meridian. It has the effects of diuresis, phlegm and blood circulation, and is often used in the treatment of hot leaching, blood leaching, stone leaching, dysuria, leaching astringent pain, and amenorrhea.
  • Tonka incense also known as smoky grass, bell scented, is a primrose plant, the herb of the genus vanillin, with roots, sweet, warm, and full of Taiyin, Yangming Jing, has the effect of removing wind cold, clearing turbid , Commonly used to treat typhoid fever, cold headache, fullness of the chest and abdomen, adverse, nocturnal emission, nasal congestion, toothache and other symptoms.
  • the anti-cancer pharmaceutical composition of the present invention is an oral pharmaceutical composition or a topical pharmaceutical composition.
  • the oral pharmaceutical composition is a tablet, capsule, granule, pill, powder, decoction;
  • the topical pharmaceutical composition is an external application cream.
  • Another object of the present invention is to provide a method for preparing an oral anticancer pharmaceutical composition, which includes the following steps:
  • an oral anticancer pharmaceutical composition is prepared according to a conventional method in the art.
  • step (2) Add the mixed particles obtained in step (1) to 5 times of purified water, adjust the pH to 12 with NaOH, heat to 60 ° C, and soak for 5 hours and filter. The filtrate is reserved. The filter residue is repeatedly extracted twice. The filtrates are combined and reduced. Pressure concentrated to extracts with a density of 1.02-1.05 at 25 ° C;
  • step (2) The extract in step (2) is prepared with a pharmaceutically acceptable auxiliary material according to a conventional method in the art to obtain an oral anticancer pharmaceutical composition.
  • Yet another object of the present invention is to provide a method for preparing an external cancer drug composition external plaster, which includes the following steps:
  • Another object of the present invention is to provide a use of a composition comprising the shark cartilage glycoprotein or shark cartilage in the preparation of an anticancer drug.
  • the shark cartilage glycoprotein is prepared by the following method:
  • the shark cartilage is crushed and passed through a 10-30 mesh sieve to obtain shark cartilage particles;
  • the anti-cancer pharmaceutical composition further comprises turtle plate, abalone shell, baking soda, clam shell, purslane, beef bone meal, Poria cocos, Shanci mushroom, sage grass, Houttuynia cordata, astragalus, Qumai, zero Lingxiang.
  • the anti-cancer drug composition comprises 5-10 parts of shark cartilage, 2-5 parts of turtle plate, 1-3 parts of abalone shell, 1-3 parts of baking soda, 1-3 parts of clam shell, and purslane 3- 8 servings, 8-15 servings of beef bone powder, 2-5 servings of Poria cocos, 5-10 servings of Shan Ci mushrooms, 2-5 servings of Saguaris, 1-3 servings of Houttuynia cordata, 1-3 servings of Astragalus, 1 serving of Qumai Made from 3 servings and 1-3 tonka incense.
  • the anticancer drug composition is composed of 80 g of shark cartilage, 30 g of tortoise shell, 20 g of abalone shell, 20 g of baking soda, 20 g of clam shell, 50 g of purslane, 100 g of beef bone powder, and 30 g of Poria 30 It is made from 80 grams, 80 grams of Shanci mushroom, 30 grams of misograss, 10 grams of houttuynia, 10 grams of astragalus, 10 grams of qumai, and 10 grams of tonka.
  • Shark cartilage glycoprotein in shark cartilage is isolated by the present invention.
  • shark cartilage glycoprotein can inhibit the proliferation of human umbilical vein endothelial cells, and can also inhibit skin cancer cells, breast cancer cells, liver cancer cells, lung cancer cells, and gastric cancer. Cell proliferation.
  • the present invention also proposes an anticancer drug composition.
  • the anticancer drug composition passes shark cartilage glycoprotein or shark cartilage and Used in other ingredients, it has achieved better anti-angiogenesis and induction of apoptosis of cancer cells than shark cartilage glycoprotein, especially the addition of tonka makes the pharmaceutical composition of the present invention unexpected. Anti-cancer effect.
  • the shark cartilage glycoprotein is prepared according to the following method:
  • Example 2 An anticancer tablet
  • Example 3 An anti-cancer external application cream
  • Example 5 An anti-cancer capsule
  • step (2) Add the mixed particles obtained in step (1) to 5 times of purified water, adjust the pH to 12 with NaOH, heat to 60 ° C, and soak for 5 hours and filter. The filtrate is reserved. The filter residue is repeatedly extracted twice. The filtrates are combined and reduced. Pressure concentrated to extracts with a density of 1.02-1.05 at 25 ° C;
  • step (3) Add the microcrystalline cellulose to the extract in step (2) to make soft materials, granulate through a 14-mesh sieve, and dry the whole granules through a 12-mesh sieve. Add an appropriate amount of magnesium stearate and fill the gelatin capsule shell. 100 caps of anti-cancer capsules were prepared.
  • Example 1 The shark cartilage glycoprotein was prepared as a suspension of 200 mg / L in sterilized PBS, the extract obtained in step (2) of Example 5, and the extract of Comparative Example 2 was suspended in 5 g of crude drug / mL using sterilized PBS. liquid.
  • Fresh human umbilical cord 15cm Wash the umbilical cord's appearance with sterilized PBS and rinse the umbilical cord veins to no residual blood. Ligation one end of the umbilical cord. Inject 2.5 g / L trypsin into the open end of the umbilical cord and digest for 20 min. Shake the umbilical cord every 3 minutes during the period. Once, after digestion is completed, the digestive solution is poured into a 50 mL sterile centrifuge tube, and the umbilical vein is rinsed twice with sterile PBS. The rinse solution is also injected into the sterile centrifuge tube, centrifuged, the supernatant is discarded, and 30 mL of sterile PBS is added and pipetted.
  • Proliferation inhibition rate (absorbance value of control group-absorbance value of experimental group) / absorbance value of control group ⁇ 100%.
  • the experimental results in Table 1 show that the extract extract of the pharmaceutical composition of the comparative group 2 without tonka also showed a certain effect of inhibiting the proliferation of human umbilical vein endothelial cells, while shark cartilage glycoprotein has a significant human umbilicus Inhibition effect of venous endothelial cells.
  • the pharmaceutical composition of the group 5 of Example 5 of the present invention shows a more excellent effect of inhibiting the proliferation of human umbilical vein endothelial cells. Its inhibition rate is about 1.7 times that of shark cartilage glycoprotein alone.
  • the inhibitory rate of the control group 2 containing tonka was 2.7 times.
  • the experimental results also suggested that the addition of tonka significantly enhanced the anti-angiogenic effect of the shark cartilage-containing pharmaceutical composition.
  • Example 1 The shark cartilage glycoprotein was prepared as a suspension of 200 mg / L in sterilized PBS, the extract obtained in step (2) of Example 5, and the extract of Comparative Example 2 was suspended in 5 g of crude drug / mL using sterilized PBS. liquid.
  • HS-4 human skin cancer cells
  • MCF-7 human breast cancer cells
  • A549 human lung adenocarcinoma cells
  • HepG2 human liver cancer cells
  • MGC80-3 human gastric cancer cells
  • the test drug is added at 50 ⁇ l / well, specifically: the blank group is added with PBS and the shark cartilage glycoprotein group A suspension of 200 mg / L of shark cartilage glycoprotein was added, the suspension of the extract obtained in Example 5 was added with 5 g of crude drug / mL in the group of Example 5, and the extract obtained in Comparative Example 2 was added with 5 g of crude drug / mL in the Comparative Example 2 group. Suspension of cream.
  • Proliferation inhibition rate (absorbance value of control group-absorbance value of experimental group) / absorbance value of control group ⁇ 100%.
  • Table 2 shows the results of the shark cartilage glycoprotein and the extract of the pharmaceutical composition of Example 5 of the present invention against human skin cancer cells, human breast cancer cells, human lung adenocarcinoma cells, human liver cancer cells, and human gastric cancer cells. All showed obvious proliferation inhibitory effects, especially against human skin cancer cells, human breast cancer cells, and human lung adenocarcinoma cell proliferation inhibition effects, indicating that the pharmaceutical composition of the present invention has excellent tumor cell proliferation inhibition effects, and Comparative group 2 of the same composition, but without tonka, has inhibitory effects on the proliferation of each tumor cell compared to the group of Example 5. The experimental results also prove that the addition of tonka can The combination of shark cartilage-containing drugs significantly inhibited tumor cell proliferation.
  • Example 4 External application cream.
  • mice Male Balb / c mice 20 mice weighing 20 ⁇ 2g, adaptive feeding for one day, mice forelimb armpit alcohol disinfectant to 5 ⁇ 10 4 cells were seeded at a concentration of mouse melanoma B16 0.2mL, successful inoculation 10 days after inoculation selection
  • mice with approximately the same tumor volume were randomly divided into two groups, specifically the model group and the group of Example 4, with five in each group, in which the model group was coated with the tumor site with physiological saline, and the group of Example 4 would be implemented
  • the external dressing cream prepared in Example 4 was applied to the tumor site once a day. After the application was completed, the coated site was covered with gauze to prevent the coating material caused by the mouse from licking, and the previous application was removed before each application.
  • mice were sacrificed by neck dissection, the tumor tissue was stripped and weighed, and the tumor suppression rate was calculated.
  • the specific experiment is shown in Table 3, where:
  • Tumor inhibition rate (tumor weight in model group-tumor weight in experimental group) / tumor weight in model group ⁇ 100%.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed are a shark cartilage glycoprotein and an anticancer use thereof. The shark cartilage glycoprotein is a shark cartilage active ingredient obtained after shark cartilage has been pulverized, extracted with alkaline water, salted out, freed of free proteins and purified. Pharmacological experiments have shown that the shark cartilage glycoprotein has anti-angiogenic effects, and can inhibit cancer cells from proliferating, such as those of skin cancer, breast cancer, non-small-cell lung cancer, liver cancer, stomach cancer and ovarian cancer. In vivo experiments have also demonstrated tumor suppression effects, showing that the invention can be applied to cancer prevention and treatment.

Description

一种鲨鱼软骨糖蛋白及其抗癌用途Shark cartilage glycoprotein and its anticancer use 技术领域Technical field
本发明属于药物领域,具体涉及一种鲨鱼软骨糖蛋白及其抗癌用途。The invention belongs to the field of medicine, and particularly relates to a shark cartilage glycoprotein and its anticancer use.
背景技术Background technique
癌症(Cancer),也称恶性肿瘤,是指控制细胞增殖的机制失常而引起的细胞失控性增殖,并局部侵入周围正常组织,甚至经由体内循环系统或淋巴系统转移到身体其他部分的一类疾病。癌症由于在其早期并无明显的临床症状,等发现时往往已处于癌症晚期,往往导致发现时已错过最佳治疗窗口期,使其致死率居高不下,成为世界五大绝症之一。我国是癌症高发地区之一,且近年来癌症的发病率正逐年升高,2014年全国新发癌症约380万例,死亡229万例。截止目前,癌症的确切致病机理仍不清楚,与癌症发病相关的因素主要有外源性因素与内源性因素,其中外源性因素包括生活习惯、环境污染、医源性因素等,内源性因素包括遗传因素、免疫因素、内分泌因素等。癌症的整体发病率虽然性别差别不大,但男性与女性中不同癌症的发病率存在明显区别,由于抽烟及近年来环境污染的加剧,肺癌为男性中发病率最高的癌症,而乳腺癌为女性发病率最高的癌症。Cancer, also known as malignant tumor, refers to a class of diseases in which the uncontrolled proliferation of cells caused by the abnormal mechanism of control of cell proliferation and local invasion of surrounding normal tissues, or even metastasis to other parts of the body via the internal circulatory system or lymphatic system . Because cancer has no obvious clinical symptoms in its early stages, it is often at the advanced stage of cancer when it is discovered, which often leads to the best treatment window missed at the time of discovery, making its mortality rate high and becoming one of the top five terminal illnesses in the world. China is one of the regions with high incidence of cancer. In recent years, the incidence of cancer is increasing year by year. In 2014, there were about 3.8 million new cancers and 2.29 million deaths. As of now, the exact pathogenesis of cancer is still unclear. The factors related to the onset of cancer mainly include exogenous and endogenous factors. Among them, exogenous factors include lifestyle habits, environmental pollution, and iatrogenic factors. Source factors include genetic factors, immune factors, and endocrine factors. Although the overall incidence of cancer is not much different, there is a significant difference in the incidence of different cancers between men and women. Due to smoking and the increase in environmental pollution in recent years, lung cancer is the most prevalent cancer among men, and breast cancer is female. The highest incidence of cancer.
针对癌症的治疗,目前主要包括手术治疗、放疗、化疗等,其中手术治疗在理论上可完全切除癌症组织,从而实现治愈癌症,但由于癌症发现时多已处于癌症晚期,癌细胞已经侵入周围正常组织或随循环系统扩散至身体其他器官,使得无法通过手术完全清楚癌症细胞,并且手术为有创性治疗手段,手术过程中伴随着癌症组织周围循环系统的破坏,一定程度上可能会促进癌细胞的扩散,加之手术所带来的伤口感染、人体免疫系统的破坏等不利影响,造成了手术治疗在癌症治疗中所发挥的作用仍然十分有限。放射治疗是使用辐射杀死癌细胞的方法,但放射治疗由于缺乏靶向性,会造成正常细胞的大面积损伤,影响患者的消化系统,破坏患者的免疫系统,使得患者自身抵御癌症的能力大幅度下降,虽然在现代放射治疗在癌症治疗过程中被广泛采用,但其也仅为权宜之计,并非治疗癌症的理想手段。化疗,全称为化学治疗,是指服用可以杀死癌症细胞的药物,从而用于治疗癌症。化疗药同样存在对正常细胞的损害,但通过化疗药物研究的不断深入,人们正努力通过靶向性给药、开发对正常组织损伤作用更小的药物,以避免化疗过程中对正常组织细胞的损伤,从而能够有效治疗癌症。At present, the treatment of cancer mainly includes surgical treatment, radiotherapy, chemotherapy, etc. Among them, surgical treatment can theoretically completely remove cancer tissue, thereby achieving cure of cancer, but since cancer is mostly in advanced stage when cancer is discovered, cancer cells have invaded the surrounding normal. Tissue or spread to other organs of the body with the circulatory system, making it impossible to completely understand cancer cells through surgery, and surgery is an invasive treatment. During the surgery, the destruction of the circulatory system surrounding cancer tissue may promote cancer cells to a certain extent The spread of the disease, combined with the adverse effects of wound infections and the destruction of the human immune system caused by surgery, has led to the limited role of surgical treatment in cancer treatment. Radiation therapy is a method of using radiation to kill cancer cells. However, due to the lack of targeting, radiation therapy can cause large-scale damage to normal cells, affect the patient's digestive system, destroy the patient's immune system, and make the patient's ability to resist cancer greater. The decrease in amplitude, although widely used in the treatment of cancer in modern radiation therapy, is only an expedient measure and is not an ideal method for treating cancer. Chemotherapy, or chemotherapeutics, refers to taking drugs that kill cancer cells and is used to treat cancer. Chemotherapy drugs also have damage to normal cells, but through the continuous development of chemotherapeutic drugs, people are working hard to develop drugs with less effect on normal tissues through targeted administration to avoid the damage to normal tissue cells during chemotherapy. Damage, which can effectively treat cancer.
上世纪80年代人们发现了鲨鱼软骨具有抑制血管生成的作用,因此逐渐将其应用于癌症的预防与治疗,但其整体治疗效果仍不理想。近年来人们先后研究了鲨鱼软骨提取物、鲨鱼软骨素、鲨鱼软骨血管生产抑制因子的抗癌效果,均未获得突破性的进展,甚至一度出现了鲨鱼软骨不具有抗癌效果的观点。In the 1980s, shark cartilage was found to have an effect of inhibiting angiogenesis, so it was gradually applied to the prevention and treatment of cancer, but its overall therapeutic effect was still not ideal. In recent years, people have studied the anti-cancer effects of shark cartilage extract, shark chondroitin, and shark cartilage angiogenesis inhibitors, and have not achieved breakthrough progress. Even the view that shark cartilage does not have anti-cancer effect has appeared.
本发明发明人在充分调研现有技术的基础上,通过大量实验,由鲨鱼软骨中分离得到了一种鲨鱼软骨糖蛋白,药理实验显示其相对于鲨鱼软骨的粗提取具有优异的抑制血管形成和促进癌细胞凋亡的效果,可用于癌症的预防和治疗。Based on a thorough investigation of the existing technology, the inventors of the present invention have isolated a shark cartilage glycoprotein from shark cartilage through a large number of experiments. Pharmacological experiments have shown that it has excellent inhibition of vascularization and The effect of promoting cancer cell apoptosis can be used for cancer prevention and treatment.
发明内容Summary of the Invention
本发明的目的是提供一种鲨鱼软骨糖蛋白在制备抗癌药物中的用途。The object of the present invention is to provide a use of shark cartilage glycoprotein in preparing an anticancer medicine.
优选的,所述鲨鱼软骨糖蛋白由以下方法制备得到:Preferably, the shark cartilage glycoprotein is prepared by the following method:
(1)鲨鱼软骨粉碎后过10-30目筛,得鲨鱼软骨颗粒;(1) The shark cartilage is crushed and passed through a 10-30 mesh sieve to obtain shark cartilage particles;
(2)鲨鱼软骨颗粒加入3-8倍的纯净水后使用NaOH调节pH为10-13,加热至50-70℃,浸泡3-10小时后过滤,滤液备用,滤渣重复浸提1-2次,滤液合并;(2) Shark cartilage granules are added with 3-8 times purified water, adjusted to pH 10-13 with NaOH, heated to 50-70 ° C, immersed for 3-10 hours and filtered, the filtrate is reserved, and the filter residue is repeatedly extracted 1-2 times The filtrates are combined;
(3)滤液经盐析后,使用Sevage法去除游离蛋白质,再经透析和DEAE-C32阴离子交互树脂柱层析后冷冻干燥制得鲨鱼软骨糖蛋白。(3) After the filtrate was subjected to salting out, free protein was removed by Sevage method, and then dialysis and DEAE-C32 anion interaction resin column chromatography were performed, followed by freeze-drying to obtain shark cartilage glycoprotein.
本发明的再一个目的是提供一种抗癌药物组合物,其包含鲨鱼软骨糖蛋白或鲨鱼软骨。It is still another object of the present invention to provide an anticancer pharmaceutical composition comprising shark cartilage glycoprotein or shark cartilage.
优选的,所述抗癌药物组合物还包含龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、山慈菇、败酱草、鱼腥草、黄芪、瞿麦、零陵香。Preferably, the anti-cancer pharmaceutical composition further comprises turtle plate, abalone shell, baking soda, clam shell, purslane, beef bone meal, Poria cocos, Shanci mushroom, sage grass, Houttuynia cordata, astragalus, Qumai, zero Lingxiang.
优选的,所述抗癌药物组合物由鲨鱼软骨5-10份、龟板2-5份、鲍鱼壳1-3份、小苏打1-3份、蛤蜊壳1-3份、马齿苋3-8份、牛骨粉8-15份、土茯苓2-5份、山慈菇5-10份、败酱草2-5份、鱼腥草1-3份、黄芪1-3份、瞿麦1-3份、零陵香1-3份制成。Preferably, the anti-cancer drug composition comprises 5-10 parts of shark cartilage, 2-5 parts of turtle plate, 1-3 parts of abalone shell, 1-3 parts of baking soda, 1-3 parts of clam shell, and purslane 3- 8 servings, 8-15 servings of beef bone powder, 2-5 servings of Poria cocos, 5-10 servings of Shan Ci mushrooms, 2-5 servings of Saguaris, 1-3 servings of Houttuynia cordata, 1-3 servings of Astragalus, 1 serving of Qumai Made from 3 servings and 1-3 tonka incense.
更优选的,所述抗癌药物组合物由鲨鱼软骨80克、龟板30克、鲍鱼壳20克、小苏打20克、蛤蜊壳20克、马齿苋50克、牛骨粉100克、土茯苓30克、山慈菇80克、败酱草30克、鱼腥草10克、黄芪10克、瞿麦10克、零陵香10克制成。More preferably, the anticancer drug composition is composed of 80 g of shark cartilage, 30 g of tortoise shell, 20 g of abalone shell, 20 g of baking soda, 20 g of clam shell, 50 g of purslane, 100 g of beef bone powder, and 30 g of Poria 30 It is made from 80 grams, 80 grams of Shanci mushroom, 30 grams of misograss, 10 grams of houttuynia, 10 grams of astragalus, 10 grams of qumai, and 10 grams of tonka.
本发明药物组合物中:In the pharmaceutical composition of the present invention:
鲨鱼软骨:具有抗肿瘤、祛风湿、止痛、止泻等多重功效,常用于风湿性关节炎、头痛、腹泻等症的治疗。Shark cartilage: It has multiple functions such as anti-tumor, rheumatism, analgesia, and diarrhea. It is often used in the treatment of rheumatoid arthritis, headache, diarrhea and other symptoms.
龟板:为龟科动物chinemys reevesii的腹甲及背甲,主要分布于浙江、湖北、湖南等地,龟板味咸甘、性平,具有滋阴、潜阳、补肾、健骨的作用,常用于骨蒸劳热、潮热、盗汗、崩漏、遗精、带下、骨痿、吐血等症的治疗,现代药理研究表明龟板具有提高机体免疫功能、抗肿瘤等作用。Turtle plate: It is the plastron and carapace of the tortoise chinemys reevesii, mainly distributed in Zhejiang, Hubei, Hunan and other places. The turtle plate tastes salty, sweet, and has the effects of nourishing yin, Qianyang, kidney, and bones. It is often used in Bone steaming fever, hot flashes, night sweats, bleeding, nocturnal emission, seminal discharge, epiphysis, vomiting and other symptoms. Modern pharmacological studies have shown that turtle plate can improve the body's immune function and anti-tumor effects.
鲍鱼壳:又称石决明,为是珍贵的药材,具有清热平肝、滋阴壮阳的功效,鲍鱼以及鲍鱼壳包含丰富的蛋白质,鲍鱼壳本身的营养价值也非常高,鲍鱼壳入药可以治疗高血压、眩晕、目暴肿疼痛等多种疾病,由鲍鱼壳中提炼出的甲壳素,还可用于胃及十二指肠溃疡、胃酸过多等症的治疗。Abalone shell: also known as stone cassia, it is a precious medicinal material, which has the functions of heat-clearing and liver-relieving, nourishing yin and aphrodisiac, abalone and abalone shell contain rich protein, and the abalone shell itself has very high nutritional value. Abalone shell can be treated with medicine. Chitin, which is extracted from abalone shells, can be used for the treatment of gastric, duodenal ulcers, and hyperacidity.
小苏打:即碳酸氢钠,化学式为NaHCO 3,小苏打溶液呈碱性,医学上外用可消毒杀菌,口服可用于治疗胃酸过多的治疗,静脉给药还可用于纠正酸中毒。现代病理研究表明肿瘤内部为酸性环境,服用小苏打,可以打破肿瘤组织酸性环境,抑制肿瘤细胞增殖。 Baking soda: Sodium bicarbonate, the chemical formula is NaHCO 3. The baking soda solution is alkaline. It can be sterilized and disinfected externally in medicine. Oral can be used to treat hyperacidity. Intravenous administration can also be used to correct acidosis. Modern pathological studies show that the tumor has an acidic environment. Taking baking soda can break the acidic environment of tumor tissues and inhibit tumor cell proliferation.
蛤蜊壳:蛤蜊味咸,性寒,具有滋阴润燥、利尿消肿、软坚散结作用。《本草经疏》中记载:″蛤蜊其性滋润而助津液,故能润五脏、止消渴,开胃也。咸能入血软坚,故主妇人血块及老癖为寒热也。″蛤蜊对肉瘤和腹水瘤都有抑制作用和缓解作用。蛤蜊壳味咸,性寒凉,可以入肺经和肾经以及肝经,能清热,也能化痰利湿,还能软坚,常用于治疗胃痛、饮喘咳、水气浮肿、小便不利、带下痈肿和烫伤等。著名方药蛤蜊散即是将蛤蜊壳洗净后置炭火烧焙,用于痰火喘咳的治疗。Clam shells: Clams are salty and cold, and they have the functions of nourishing yin, moisturizing, diuretic, swelling, soft and firm. "Ben Cao Jing Shu" records: "Clams are moisturizing and help tonic fluid, so they can moisten the internal organs, quench thirst, and appetite. Salty can soften blood, so the housewife's blood clots and old habits are also cold and hot." And ascites tumors have inhibitory and relieving effects. Clam shells are salty, cold, and can enter the lung, kidney, and liver meridians. They can clear heat, relieve phlegm, dampness, and softness. They are often used to treat stomach pain, cough, cough, edema, and urination. Bloated and scalded. The well-known herbal clam powder is that the clam shells are washed and then charcoal fired and roasted for the treatment of phlegm, fire and cough.
马齿苋:为马齿苋科植物马齿苋的干燥地上部分,味酸、性寒,归肝、大肠经,有清热利湿、解毒消肿、消炎、止渴、利尿的效果,常用于热毒血痢、痈肿疔疮、湿疹、丹毒、蛇虫咬 伤、便血、崩漏等症的治疗。Purslane: It is the dry aerial part of purslane, purslane, sour, cold, returning to the liver, large intestine, and has the effects of clearing heat and dampness, detoxification and swelling, anti-inflammatory, thirst quenching, and diuretic. It is commonly used in Treatment of fever, blood poisoning, carbuncle, scabies, eczema, erysipelas, snake bite, blood in the stool, and leakage.
牛骨粉:为牛科野牛属动物黄牛或水牛属动物水牛的骨骼,味甘、性温,具有蠲痹、截疟、敛疮等功效,常用于关节炎、泻痢、疟疾、疳疮等症的治疗。骨中所含的骨髓自古就有″补精髓、壮筋骨、延年益寿″的记载,古籍《寿世真元》认为:骨髓″专补虚损,活血荣筋,润泽肌肤,返老还童″,是抗衰老的造血器官,能增进人体的造血机能,提高肌体免疫力,含有人体所需的全部营养精华,有促进儿童大脑发育、健脑增智之功效的卵磷脂;有滋润皮肤、美容养颜、防衰老的骨胶原(多种氨基酸)、粘多糖和多种蛋白肽等。牛骨还储藏着丰富的营养,其蛋白质、铁质、钠和产生的能量远远高于鲜肉,蛋白质含量高出奶粉23%,是猪肉的两倍,高出牛肉61%,是鸡蛋的1倍多,磷、钙含量更是其它食物所不能比拟的。尤其难得的是,牛骨的营养成分比植物蛋白更易为人体所吸收。Bovine Bone Meal: It is the bone of the bovine bison ox or buffalo buffalo. It is sweet and warm. It has the functions of paralysis, truncation, and astringent sores. It is often used for arthritis, diarrhea, malaria, scabies, etc. Treatment. The bone marrow contained in the bone has been recorded since ancient times as "replenishing the essence, strengthening the bones, and prolonging life". The ancient book "Shou Shi Zhen Yuan" believes that the bone marrow "specially repairs damage, promotes blood circulation, strengthens the skin, rejuvenates the skin, and returns to the age of children", and is anti-aging Hematopoietic organs can enhance the body's hematopoietic function and improve the body's immunity. It contains all the nutritional essentials needed by the human body, and has lecithin that promotes children's brain development and brain health. It also has moisturizing skin, beauty and anti-aging bone. Collagen (multiple amino acids), mucopolysaccharides and multiple protein peptides. Beef bone also stores a wealth of nutrients. Its protein, iron, sodium, and energy are much higher than fresh meat. The protein content is 23% higher than milk powder, twice that of pork, and 61% higher than beef. It is egg. More than 1 time, the content of phosphorus and calcium is unmatched by other foods. Particularly rare is that the nutritional components of bovine bone are more easily absorbed by the body than plant proteins.
土茯苓:为百合科植物光叶菝葜的干燥根茎,味甘、淡,性平。有解毒除湿、同理关节的功效,常用于梅毒及汞中毒所致的肢体拘挛、筋骨疼痛、湿热淋浊、带下、痈肿、瘰疬、疥癣等症的治疗。Poria cocos: It is a dry rhizome of Liliaceae, Phyllostachys pubescens, which is sweet, light and flat. It has the effects of detoxification and dehumidification, and the same joints. It is often used for the treatment of limb constriction caused by syphilis and mercury poisoning.
山慈菇:为兰科植物杜鹃兰、独蒜兰或云南独蒜兰的干燥假鳞茎,味甘、微辛,性凉,归肝、脾经。具有清热解毒,消痈散结的功效,常用于痈肿疔毒、瘰疬病核、蛇虫咬伤等症的治疗。Shanci mushroom: It is a dried pseudobulb of the orchid family Rhododendron Orchid, Orchid Orchid, or Yunnan Orchid Orchid. It is sweet, slightly spicy, cool, and belongs to the liver and spleen. It has the effect of clearing heat and detoxifying, eliminating spleen and dissolving stagnation, and is often used for the treatment of bloated and swollen venom, rickets, and snake bite.
败酱草:为败酱科植物白花败酱的干燥全草,味辛、苦,性凉,归肝、胃、大肠经,具有清热解毒、祛痰排脓的功效,常用于肠痈、肺痈、痢疾、痈肿疔疮等症的治疗。Scaly grass: The dried whole grass of Scalyaceae white flower Scaly sauce, tastes bitter, bitter, cool, and returns to the liver, stomach, and large intestine meridian. It has the functions of clearing heat and detoxifying, expectorant and purulent, and is often used in intestines and lungs. Treatment of dysentery, dysentery, swollen scabies.
鱼腥草:为三白草科植物蕺菜的干燥地上部分,味辛,性寒凉,归肺经。具有清热解毒、消肿排脓疗疮、利尿除湿、清热止痢、健胃消食的功效,可用于治疗肺脓溃疡、肺热咳喘、热痢热淋、水肿、脚气、尿路感染、白带过多、痈肿疮毒等症,现代药理研究表明,鱼腥草还具有抗菌、抗病毒、提高机体免疫力,利尿等作用。临床实践证明鱼腥草对于上呼吸道感染、支气管炎、肺炎、慢性气管炎、慢性宫颈炎、百日咳等均有较好的疗效,对急性结膜炎、尿路感染等也有一定疗效。Houttuynia cordata: It is the dry aerial part of amaranthaceae plant Amaranth. It has the functions of clearing heat and detoxifying, reducing swelling and purging sore, diuretic and dehumidifying, clearing heat and stopping dysentery, strengthening stomach and digesting food, and can be used to treat lung pus ulcer, lung heat cough and asthma, fever, hot shower, edema, beriberi, urinary infection Excessive, swollen, sore, and so on. Modern pharmacological studies have shown that Houttuynia cordata also has antibacterial, antiviral, body immunity, and diuretic effects. Clinical practice has proven that Houttuynia cordata has good effects on upper respiratory tract infections, bronchitis, pneumonia, chronic bronchitis, chronic cervicitis, and pertussis, and it also has certain effects on acute conjunctivitis and urinary tract infections.
黄芪:为豆科植物蒙古黄芪的根,味甘、性温,归肺、脾、肝、肾经。具有补气固表、托毒排脓、利尿、生肌的功效,常用于气虚乏力、久泻脱肛、自汗、水肿、子宫脱垂、糖尿病、创口久不愈合等症的治疗。Astragalus membranaceus: Mongolian astragalus root is a legume, sweet and warm, and belongs to the lungs, spleen, liver and kidney. It has the effects of replenishing qi and solid surface, detoxifying and purging, diuretic, and muscle growth. It is often used for the treatment of qi deficiency and fatigue, chronic diarrhea and prolapse, spontaneous sweating, edema, uterine prolapse, diabetes, and long-term non-healing of wounds.
瞿麦:为石竹科植物瞿麦的干燥地上部分,味苦,性寒,归心、小肠经。具有利尿通淋、活血通经的功效,常用于热淋、血淋、石淋、小便不通、淋沥涩痛、经闭等症的治疗。Qumai: It is the dry aerial part of the Dianthus plant Qumai, which has bitter taste, coldness, homesickness, and small intestine meridian. It has the effects of diuresis, phlegm and blood circulation, and is often used in the treatment of hot leaching, blood leaching, stone leaching, dysuria, leaching astringent pain, and amenorrhea.
零陵香:又称熏草、铃铃香,为报春花科植物灵香草的带根全草,味辛甘,性温,归足太阴、阳明经,具有祛风寒、辟秽浊的功效,常用于治疗伤寒、感冒头痛、胸腹胀满、不利、遗精、鼻塞、牙痛等症。Tonka incense: also known as smoky grass, bell scented, is a primrose plant, the herb of the genus vanillin, with roots, sweet, warm, and full of Taiyin, Yangming Jing, has the effect of removing wind cold, clearing turbid , Commonly used to treat typhoid fever, cold headache, fullness of the chest and abdomen, adverse, nocturnal emission, nasal congestion, toothache and other symptoms.
本发明抗癌药物组合物为口服药物组合物或局部施用药物组合物。The anti-cancer pharmaceutical composition of the present invention is an oral pharmaceutical composition or a topical pharmaceutical composition.
优选的,所述口服药物组合物为为片剂、胶囊剂、颗粒剂、丸剂、散剂、汤剂;所述局部施用药物组合物为外敷膏剂。Preferably, the oral pharmaceutical composition is a tablet, capsule, granule, pill, powder, decoction; the topical pharmaceutical composition is an external application cream.
本发明的再一个目的是提供一种口服抗癌药物组合物的制备方法,包括以下步骤:Another object of the present invention is to provide a method for preparing an oral anticancer pharmaceutical composition, which includes the following steps:
鲨鱼软骨糖蛋白添加药学上可接受的辅料后,按照本领域常规方法制得口服抗癌药物组合物。、After the shark cartilage glycoprotein is added with a pharmaceutically acceptable excipient, an oral anticancer pharmaceutical composition is prepared according to a conventional method in the art. ,
或按照以下步骤制备的到:Or follow these steps:
(1)将鲨鱼软骨、龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、山慈菇、败酱草、鱼腥草、黄芪、瞿麦、零陵香各自粉碎成20目颗粒后混匀;(1) Crush the shark cartilage, tortoise shell, abalone shell, baking soda, clam shell, purslane, beef bone meal, Poria cocos, Shanci mushroom, sauerkraut, Houttuynia cordata, Astragalus membranaceus, Qumai, Tonka fragrant into each Mix after 20 mesh particles;
(2)将步骤(1)所得混合颗粒加入5倍的纯净水后使用NaOH调节pH为12,加热至60℃,浸泡5小时后过滤,滤液备用,滤渣重复浸提2次,滤液合并,减压浓缩为25℃时密度为1.02-1.05的浸膏;(2) Add the mixed particles obtained in step (1) to 5 times of purified water, adjust the pH to 12 with NaOH, heat to 60 ° C, and soak for 5 hours and filter. The filtrate is reserved. The filter residue is repeatedly extracted twice. The filtrates are combined and reduced. Pressure concentrated to extracts with a density of 1.02-1.05 at 25 ° C;
(3)步骤(2)所的浸膏药学上可接受的辅料后按照本领域常规方法制备得到口服抗癌药物组合物。(3) The extract in step (2) is prepared with a pharmaceutically acceptable auxiliary material according to a conventional method in the art to obtain an oral anticancer pharmaceutical composition.
本发明的再一个目的是提供一种抗癌药物组合物外敷膏剂的制备方法,包括以下步骤:Yet another object of the present invention is to provide a method for preparing an external cancer drug composition external plaster, which includes the following steps:
(1)将鲨鱼软骨、龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、山慈菇、败酱草、鱼腥草、黄芪、瞿麦、零陵香粉碎成150-200目颗粒;(1) Crush shark cartilage, tortoise shell, abalone shell, baking soda, clam shell, purslane, beef bone meal, earthy Poria, Shanci mushroom, sauerkraut, Houttuynia cordata, Astragalus, Qumai, Linglingxiang to 150 -200 mesh particles;
(2)将鱼腥草、零陵香、山慈菇、败酱草颗粒使用海盐泡水48小时,使用时,使用该水将鲨鱼软骨、龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、黄芪、瞿麦颗粒调成药膏,即得外敷膏剂。(2) Soak the water of Houttuynia cordatum, Tonka fragrant, Shanci mushroom, and rotten grass with sea salt for 48 hours. When using, use this water to shark cartilage, turtle plate, abalone shell, baking soda, clam shell, horse teeth Loquat, beef bone powder, Poria cocos, Astragalus and Qumai granules are prepared into ointments to obtain an external plaster.
本发明的再一个目的提供一种包含所述鲨鱼软骨糖蛋白或鲨鱼软骨的组合物在制备抗癌药物中的用途,所述鲨鱼软骨糖蛋白由以下方法制备得到:Another object of the present invention is to provide a use of a composition comprising the shark cartilage glycoprotein or shark cartilage in the preparation of an anticancer drug. The shark cartilage glycoprotein is prepared by the following method:
(1)鲨鱼软骨粉碎后过10-30目筛,得鲨鱼软骨颗粒;(1) The shark cartilage is crushed and passed through a 10-30 mesh sieve to obtain shark cartilage particles;
(2)鲨鱼软骨颗粒加入3-8倍的纯净水后使用NaOH调节pH为10-13,加热至50-70℃,浸泡3-10小时后过滤,滤液备用,滤渣重复浸提1-2次,滤液合并;(2) Shark cartilage granules are added with 3-8 times purified water, adjusted to pH 10-13 with NaOH, heated to 50-70 ° C, immersed for 3-10 hours and filtered, the filtrate is reserved, and the filter residue is repeatedly extracted 1-2 times The filtrates are combined;
(3)滤液经盐析后,使用Sevage法去除游离蛋白质,再经透析和DEAE-C32阴离子交互树脂柱层析后冷冻干燥制得鲨鱼软骨糖蛋白。(3) After the filtrate was subjected to salting out, free protein was removed by Sevage method, and then dialysis and DEAE-C32 anion interaction resin column chromatography were performed, followed by freeze-drying to obtain shark cartilage glycoprotein.
优选的,所述抗癌药物组合物还包含龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、山慈菇、败酱草、鱼腥草、黄芪、瞿麦、零陵香。Preferably, the anti-cancer pharmaceutical composition further comprises turtle plate, abalone shell, baking soda, clam shell, purslane, beef bone meal, Poria cocos, Shanci mushroom, sage grass, Houttuynia cordata, astragalus, Qumai, zero Lingxiang.
优选的,所述抗癌药物组合物由鲨鱼软骨5-10份、龟板2-5份、鲍鱼壳1-3份、小苏打1-3份、蛤蜊壳1-3份、马齿苋3-8份、牛骨粉8-15份、土茯苓2-5份、山慈菇5-10份、败酱草2-5份、鱼腥草1-3份、黄芪1-3份、瞿麦1-3份、零陵香1-3份制成。Preferably, the anti-cancer drug composition comprises 5-10 parts of shark cartilage, 2-5 parts of turtle plate, 1-3 parts of abalone shell, 1-3 parts of baking soda, 1-3 parts of clam shell, and purslane 3- 8 servings, 8-15 servings of beef bone powder, 2-5 servings of Poria cocos, 5-10 servings of Shan Ci mushrooms, 2-5 servings of Saguaris, 1-3 servings of Houttuynia cordata, 1-3 servings of Astragalus, 1 serving of Qumai Made from 3 servings and 1-3 tonka incense.
更优选的,所述抗癌药物组合物由鲨鱼软骨80克、龟板30克、鲍鱼壳20克、小苏打20克、蛤蜊壳20克、马齿苋50克、牛骨粉100克、土茯苓30克、山慈菇80克、败酱草30克、鱼腥草10克、黄芪10克、瞿麦10克、零陵香10克制成。More preferably, the anticancer drug composition is composed of 80 g of shark cartilage, 30 g of tortoise shell, 20 g of abalone shell, 20 g of baking soda, 20 g of clam shell, 50 g of purslane, 100 g of beef bone powder, and 30 g of Poria 30 It is made from 80 grams, 80 grams of Shanci mushroom, 30 grams of misograss, 10 grams of houttuynia, 10 grams of astragalus, 10 grams of qumai, and 10 grams of tonka.
本发明有益效果Beneficial effects of the present invention
本发明分离得到了鲨鱼软骨中的鲨鱼软骨糖蛋白,体外实验显示鲨鱼软骨糖蛋白具有抑制人脐静脉内皮细胞增殖的作用,还可以抑制皮肤癌细胞、乳腺癌细胞、肝癌细胞、肺癌细胞、胃癌细胞的增殖。Shark cartilage glycoprotein in shark cartilage is isolated by the present invention. In vitro experiments show that shark cartilage glycoprotein can inhibit the proliferation of human umbilical vein endothelial cells, and can also inhibit skin cancer cells, breast cancer cells, liver cancer cells, lung cancer cells, and gastric cancer. Cell proliferation.
本发明在发现鲨鱼软骨糖蛋白可以有效抗血管形成,诱导癌细胞凋亡的基础上,还提出了一种抗癌药物组合物,所述抗癌药物组合物通过鲨鱼软骨糖蛋白或鲨鱼软骨与其他成分配伍使用,取得了相对于鲨鱼软骨糖蛋白更为优异的抗血管形成和诱导癌细胞凋亡的效果,尤其是零陵香的加入,使得本发明的药物组合物取得了意料不到的抗癌效果。On the basis of finding that shark cartilage glycoprotein can effectively resist angiogenesis and induce apoptosis of cancer cells, the present invention also proposes an anticancer drug composition. The anticancer drug composition passes shark cartilage glycoprotein or shark cartilage and Used in other ingredients, it has achieved better anti-angiogenesis and induction of apoptosis of cancer cells than shark cartilage glycoprotein, especially the addition of tonka makes the pharmaceutical composition of the present invention unexpected. Anti-cancer effect.
具体实施方式detailed description
在下文中更详细地描述了本发明以有助于对本发明的理解。The invention is described in more detail below to facilitate an understanding of the invention.
实施例1:一种鲨鱼软骨糖蛋白Example 1: A shark cartilage glycoprotein
所述鲨鱼软骨糖蛋白按照以下方法制备:The shark cartilage glycoprotein is prepared according to the following method:
(1)鲨鱼软骨200g,粉碎后过20目筛,得鲨鱼软骨颗粒;(1) Shark cartilage 200g, crushed and passed through a 20 mesh sieve to obtain shark cartilage particles;
(2)鲨鱼软骨颗粒加入5倍的纯净水后使用NaOH调节pH为12,加热至60℃,浸泡5小时后过滤,滤液备用,滤渣重复浸提2次,滤液合并;(2) Shark cartilage particles are added with 5 times purified water, adjusted to pH 12 with NaOH, heated to 60 ° C, and immersed for 5 hours, then filtered, and the filtrate is reserved. The filter residue is repeatedly extracted twice, and the filtrates are combined;
(3)滤液经盐析后,使用Sevage法去除游离蛋白质,再经透析和DEAE-C32阴离子交互树脂柱层析后,冷冻干燥制得鲨鱼软骨糖蛋白5.6g。(3) After salting out the filtrate, use Sevage method to remove free protein, and then dialysis and DEAE-C32 anion interaction resin column chromatography, freeze-drying to obtain 5.6 g of shark cartilage glycoprotein.
实施例2:一种抗癌片剂Example 2: An anticancer tablet
鲨鱼软骨糖蛋白30克、微晶纤维素230g、羟丙基纤维素25g、羧甲基淀粉钠15g、硬脂酸镁适量,按照以下方法制备:30 g of shark cartilage glycoprotein, 230 g of microcrystalline cellulose, 25 g of hydroxypropyl cellulose, 15 g of sodium carboxymethyl starch, and appropriate amount of magnesium stearate were prepared according to the following method:
鲨鱼软骨糖蛋白粉碎过60目筛,添加微晶纤维素后使用羟丙基纤维素制软才,过14目筛制粒,干燥后过12目筛整粒,加入羧甲基淀粉钠及硬脂酸镁后混匀,压片得抗癌片剂1000片。Shark cartilage glycoprotein was smashed through a 60-mesh sieve, after adding microcrystalline cellulose, hydroxypropylcellulose was used for softening, and after 14-mesh sieve was used for granulation. After drying, it was sieved into a whole particle with carboxymethyl starch sodium and hard After mixing the magnesium stearate, it was compressed to obtain 1000 anticancer tablets.
实施例3:一种抗癌外敷膏剂Example 3: An anti-cancer external application cream
鲨鱼软骨糖蛋白3克、龟板30克、鲍鱼壳20克、小苏打20克、蛤蜊壳20克、马齿苋50克、牛骨粉100克、土茯苓30克、山慈菇80克、败酱草30克、鱼腥草10克、黄芪10克、瞿麦10克、零陵香10克,按照以下方法制备:3 grams of shark cartilage glycoprotein, 30 grams of turtle plate, 20 grams of abalone shell, 20 grams of baking soda, 20 grams of clam shells, 50 grams of purslane, 100 grams of beef bone meal, 30 grams of Poria cocklebur, 80 grams of mountain mushroom 30 grams of grass, 10 grams of houttuynia cordata, 10 grams of astragalus, 10 grams of qumai, 10 grams of tonka, prepared according to the following method:
(1)将龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、山慈菇、败酱草、鱼腥草、黄芪、瞿麦、零陵香粉碎成180目颗粒;(1) Crush the turtle plate, abalone shell, baking soda, clam shell, purslane, beef bone meal, earth Poria, Shanci mushroom, mischievous grass, houttuynia cordata, astragalus, qumai, tonka incense into 180 mesh particles;
(2)将鱼腥草、零陵香、山慈菇、败酱草颗粒使用海盐泡水48小时,使用时,使用该水将鲨鱼软骨糖蛋白与龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、黄芪、瞿麦颗粒调成药膏,即得外敷膏剂。(2) Use Houttuynia cordata, Tonka fragrant, Shanci mushroom, and Saponaria granules to soak water in sea salt for 48 hours. During use, use this water to combine shark cartilage glycoprotein with turtle plate, abalone shell, baking soda, clam shell, Portulaca oleracea, bovine bone powder, Poria cocos, Astragalus and Qumai granules are prepared into ointments to obtain an external plaster.
实施例4:一种抗癌外敷膏剂Example 4: An anti-cancer external plaster
鲨鱼软骨80克、龟板30克、鲍鱼壳20克、小苏打20克、蛤蜊壳20克、马齿苋50克、牛骨粉100克、土茯苓30克、山慈菇80克、败酱草30克、鱼腥草10克、黄芪10克、瞿麦10克、零陵香10克,按照以下方法制备:Shark cartilage 80g, turtle plate 30g, abalone shell 20g, baking soda 20g, clam shell 20g, purslane 50g, beef bone powder 100g, earthy poria 30g, mountain citron 80g G, Houttuynia cordata 10 g, Astragalus 10 g, Qumai 10 g, Tonka incense 10 g, prepared according to the following method:
(1)将鲨鱼软骨、龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、山慈菇、败酱草、鱼腥草、黄芪、瞿麦、零陵香粉碎成180目颗粒;(1) Crush shark cartilage, tortoise shell, abalone shell, baking soda, clam shell, purslane, beef bone meal, earthy Poria, Shanci mushroom, sauerkraut, Houttuynia cordata, Astragalus, Qumai, Tonka fragrant into 180 Mesh particle
(2)将鱼腥草、零陵香、山慈菇、败酱草颗粒使用海盐泡水48小时,使用时,使用该水将鲨鱼软骨糖蛋白与龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、黄芪、瞿麦颗粒调成药膏,即得外敷膏剂。(2) Use Houttuynia cordata, Tonka fragrant, Shanci mushroom, and Saponaria granules to soak water in sea salt for 48 hours. During use, use this water to combine shark cartilage glycoprotein with turtle plate, abalone shell, baking soda, clam shell, Portulaca oleracea, bovine bone powder, Poria cocos, Astragalus and Qumai granules are prepared into ointments to obtain an external plaster.
实施例5:一种抗癌胶囊剂Example 5: An anti-cancer capsule
鲨鱼软骨80克、龟板30克、鲍鱼壳20克、小苏打20克、蛤蜊壳20克、马齿苋50克、牛骨粉100克、土茯苓30克、山慈菇80克、败酱草30克、鱼腥草10克、黄芪10克、瞿麦10克、零陵香10克,按照以下方法制备:Shark cartilage 80g, turtle plate 30g, abalone shell 20g, baking soda 20g, clam shell 20g, purslane 50g, beef bone powder 100g, earthy poria 30g, mountain citron 80g G, Houttuynia cordata 10 g, Astragalus 10 g, Qumai 10 g, Tonka incense 10 g, prepared according to the following method:
(1)将鲨鱼软骨、龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、山慈菇、 败酱草、鱼腥草、黄芪、瞿麦、零陵香各自粉碎成20目颗粒后混匀;(1) Crush the shark cartilage, turtle plate, abalone shell, baking soda, clam shell, purslane, beef bone meal, earth Poria, Shanci mushroom, sauerkraut, Houttuynia cordata, astragalus, qumai, tonka, respectively. Mix after 20 mesh particles;
(2)将步骤(1)所得混合颗粒加入5倍的纯净水后使用NaOH调节pH为12,加热至60℃,浸泡5小时后过滤,滤液备用,滤渣重复浸提2次,滤液合并,减压浓缩为25℃时密度为1.02-1.05的浸膏;(2) Add the mixed particles obtained in step (1) to 5 times of purified water, adjust the pH to 12 with NaOH, heat to 60 ° C, and soak for 5 hours and filter. The filtrate is reserved. The filter residue is repeatedly extracted twice. The filtrates are combined and reduced. Pressure concentrated to extracts with a density of 1.02-1.05 at 25 ° C;
(3)步骤(2)所的浸膏添加微晶纤维素后制软材,过14目筛制粒,干燥后过12目筛整粒,添加适量硬脂酸镁后灌装于明胶胶囊壳,制得抗癌胶囊100粒。(3) Add the microcrystalline cellulose to the extract in step (2) to make soft materials, granulate through a 14-mesh sieve, and dry the whole granules through a 12-mesh sieve. Add an appropriate amount of magnesium stearate and fill the gelatin capsule shell. 100 caps of anti-cancer capsules were prepared.
对比例1:一种抗癌药物组合物Comparative Example 1: An anticancer drug composition
鲨鱼软骨80克、龟板30克、鲍鱼壳20克、小苏打20克、蛤蜊壳20克、马齿苋50克、牛骨粉100克、土茯苓30克、山慈菇80克、败酱草30克、鱼腥草10克、黄芪10克、瞿麦10克,按照实施例4步骤制备得到外敷膏剂。Shark cartilage 80g, turtle plate 30g, abalone shell 20g, baking soda 20g, clam shell 20g, purslane 50g, beef bone powder 100g, earthy poria 30g, mountain citron 80g G, Houttuynia cordata 10 g, Astragalus 10 g, Qumai 10 g were prepared according to the procedure of Example 4 to obtain an external application cream.
对比例2:一种抗癌药物组合物Comparative Example 2: An anticancer drug composition
鲨鱼软骨80克、龟板30克、鲍鱼壳20克、小苏打20克、蛤蜊壳20克、马齿苋50克、牛骨粉100克、土茯苓30克、山慈菇80克、败酱草30克、鱼腥草10克、黄芪10克、瞿麦10克,按照实施例5步骤制备得到浸膏。Shark cartilage 80g, turtle plate 30g, abalone shell 20g, baking soda 20g, clam shell 20g, purslane 50g, beef bone powder 100g, earthy poria 30g, mountain citron 80g Grams, 10 grams of Houttuynia cordata, 10 grams of Astragalus membranaceus, and 10 grams of Qumai were prepared according to the steps of Example 5 to obtain an extract.
效果例1本发明药物组合物的抗血管形成作用Effect Example 1 Anti-angiogenic effect of the pharmaceutical composition of the present invention
1.1实验药物1.1 Experimental drugs
实施例1鲨鱼软骨糖蛋白使用灭菌PBS配制为200mg/L的悬浮液、实施例5步骤(2)所得浸膏、对比例2浸膏均使用灭菌PBS配置为5g生药/mL的混悬液。Example 1 The shark cartilage glycoprotein was prepared as a suspension of 200 mg / L in sterilized PBS, the extract obtained in step (2) of Example 5, and the extract of Comparative Example 2 was suspended in 5 g of crude drug / mL using sterilized PBS. liquid.
1.2实验方法1.2 Experimental methods
新鲜人脐带15cm,使用灭菌PBS清洗脐带外表并冲洗脐带静脉至无残血,结扎脐带一端,在脐带开口端静脉内灌注2.5g/L胰蛋白酶后,消化20min,期间每隔3分钟摇晃脐带一次,消化完成后将消化液注入50mL无菌离心管中,再使用灭菌PBS冲洗脐静脉2次,冲洗液同样注入无菌离心管中,离心,弃上清,加入灭菌PBS30mL后,吹打均匀后再次离心,弃上清,沉淀加入含10%新生牛血清的DMEM培养基,加入24孔板,放置于37℃、5%湿度的CO 2培养箱中培养24h,更换含10%新生牛血清的DMEM培养基后继续培养24小时,得原代分离的人脐静脉内皮细胞。 Fresh human umbilical cord 15cm. Wash the umbilical cord's appearance with sterilized PBS and rinse the umbilical cord veins to no residual blood. Ligation one end of the umbilical cord. Inject 2.5 g / L trypsin into the open end of the umbilical cord and digest for 20 min. Shake the umbilical cord every 3 minutes during the period. Once, after digestion is completed, the digestive solution is poured into a 50 mL sterile centrifuge tube, and the umbilical vein is rinsed twice with sterile PBS. The rinse solution is also injected into the sterile centrifuge tube, centrifuged, the supernatant is discarded, and 30 mL of sterile PBS is added and pipetted. After homogenization, centrifuge again, discard the supernatant, add DMEM medium containing 10% newborn bovine serum, add it to a 24-well plate, and place it in a CO 2 incubator at 37 ° C and 5% humidity for 24 hours. Replace with 10% newborn cattle The serum was further cultured in DMEM medium for 24 hours to obtain primary isolated human umbilical vein endothelial cells.
原代分离的人脐静脉内皮细胞用0.05%的胰酶消化后,以2×10 4个/mL的密度接种于96孔板,200μl/孔,共4组,具体为空白组、鲨鱼软骨糖蛋白组、实施例5组、对比例2组,每组设置3个平行孔,放置于37℃、5%湿度的CO 2培养箱培养24h,加入测试药物50μl/孔,具体的为:空白组加入PBS、鲨鱼软骨糖蛋白组加入鲨鱼软骨糖蛋白200mg/L的混悬液,实施例5组加入5g生药/mL的实施例5所得浸膏的混悬液、对比例2组添加加入5g生药/mL的对比例2所得浸膏的混悬液。继续培养24h后,弃去上清,加入5mg/ml MTT试剂20μL和200μL DMSO,3h后使用酶标仪测试570nm吸光度值,计算各组的人脐静脉内皮细胞增殖抑制率,具体结果见表1,其中: Primary isolated human umbilical vein endothelial cells were digested with 0.05% trypsin, and then seeded into 96-well plates at a density of 2 × 10 4 cells / mL, 200 μl / well, in a total of 4 groups, specifically blank group, shark cartilage sugar Protein group, Example 5 group, Comparative Example 2 group, each group is provided with 3 parallel wells, placed in a CO 2 incubator at 37 ° C. and 5% humidity for 24 hours, and added with a test drug 50 μl / well, specifically: a blank group PBS was added, the shark cartilage glycoprotein group was added with a 200 mg / L suspension of shark cartilage glycoprotein, the suspension of the extract obtained in Example 5 was added with 5 g of crude drug / mL in the group of Example 5, and the control group 2 was added with 5 g of crude drug. / mL of a suspension of the extract obtained in Comparative Example 2. After 24 hours of incubation, the supernatant was discarded, and 5 mg / ml MTT reagent 20 μL and 200 μL DMSO were added. After 3 hours, the absorbance value at 570 nm was measured using a microplate reader, and the inhibition rate of human umbilical vein endothelial cells in each group was calculated. The specific results are shown in Table 1. ,among them:
增殖抑制率=(对照组吸光度值-实验组吸光度值)/对照组吸光度值×100%。Proliferation inhibition rate = (absorbance value of control group-absorbance value of experimental group) / absorbance value of control group × 100%.
1.3实验结果1.3 Experimental results
表1本发明药物组合物对人脐静脉内皮细胞的增殖抑制作用Table 1 Inhibitory effect of the pharmaceutical composition of the present invention on human umbilical vein endothelial cells
Figure PCTCN2019086298-appb-000001
Figure PCTCN2019086298-appb-000001
表1实验结果显示,不含零陵香的对比例2组药物组合物的提取物浸膏也显示了一定的抑制人脐静脉内皮细胞增殖的效果,而鲨鱼软骨糖蛋白则具有明显的人脐静脉内皮细胞的增殖抑制效果,本发明实施例5组药物组合物则显示了更为优异的人脐静脉内皮细胞的增殖抑制效果,其抑制率约为单独鲨鱼软骨糖蛋白的1.7倍,为不含零陵香的对比例2组抑制率的2.7倍,该实验结果也提示了零陵香的加入显著增强含鲨鱼软骨的药物组合物的的抗血管形成效果。The experimental results in Table 1 show that the extract extract of the pharmaceutical composition of the comparative group 2 without tonka also showed a certain effect of inhibiting the proliferation of human umbilical vein endothelial cells, while shark cartilage glycoprotein has a significant human umbilicus Inhibition effect of venous endothelial cells. The pharmaceutical composition of the group 5 of Example 5 of the present invention shows a more excellent effect of inhibiting the proliferation of human umbilical vein endothelial cells. Its inhibition rate is about 1.7 times that of shark cartilage glycoprotein alone. The inhibitory rate of the control group 2 containing tonka was 2.7 times. The experimental results also suggested that the addition of tonka significantly enhanced the anti-angiogenic effect of the shark cartilage-containing pharmaceutical composition.
效果例2:本发明药物组合物对肿瘤细胞的生长抑制效果Effect Example 2: Growth inhibition effect of the pharmaceutical composition of the present invention on tumor cells
2.1实验药物2.1 Experimental drugs
实施例1鲨鱼软骨糖蛋白使用灭菌PBS配制为200mg/L的悬浮液、实施例5步骤(2)所得浸膏、对比例2浸膏均使用灭菌PBS配置为5g生药/mL的混悬液。Example 1 The shark cartilage glycoprotein was prepared as a suspension of 200 mg / L in sterilized PBS, the extract obtained in step (2) of Example 5, and the extract of Comparative Example 2 was suspended in 5 g of crude drug / mL using sterilized PBS. liquid.
2.2实验方法2.2 Experimental methods
细胞系:HS-4(人皮肤癌细胞)、MCF-7(人乳腺癌细胞)、A549(人肺腺癌细胞)、HepG2(人肝癌细胞)、MGC80-3(人胃癌细胞)Cell lines: HS-4 (human skin cancer cells), MCF-7 (human breast cancer cells), A549 (human lung adenocarcinoma cells), HepG2 (human liver cancer cells), MGC80-3 (human gastric cancer cells)
取对数生长期的以上细胞系,以2×10 4个/mL的密度接种于96孔板,200μl/孔,共4组,具体为空白组、鲨鱼软骨糖蛋白组、实施例5组、对比例2组,每组设置3个平行孔,放置于37℃、5%湿度的CO 2培养箱培养24h,加入测试药物50μl/孔,具体的为:空白组加入PBS、鲨鱼软骨糖蛋白组加入鲨鱼软骨糖蛋白200mg/L的混悬液,实施例5组加入5g生药/mL的实施例5所得浸膏的混悬液、对比例2组添加加入5g生药/mL的对比例2所得浸膏的混悬液。继续培养24h后,弃去上清,加入5mg/ml MTT试剂20μL和200μL DMSO,3h后使用酶标仪测试570nm吸光度值,计算各组的肿瘤细胞增殖抑制率,具体结果见表2,其中: Take the above cell lines in the logarithmic growth phase and inoculate them into 96-well plates at a density of 2 × 10 4 cells / mL at 200 μl / well in a total of 4 groups, specifically the blank group, the shark cartilage glycoprotein group, the Example 5 group, Comparative example 2 groups, each group is provided with 3 parallel wells, placed in a CO 2 incubator at 37 ° C. and 5% humidity for 24 hours, and the test drug is added at 50 μl / well, specifically: the blank group is added with PBS and the shark cartilage glycoprotein group A suspension of 200 mg / L of shark cartilage glycoprotein was added, the suspension of the extract obtained in Example 5 was added with 5 g of crude drug / mL in the group of Example 5, and the extract obtained in Comparative Example 2 was added with 5 g of crude drug / mL in the Comparative Example 2 group. Suspension of cream. After 24 hours of incubation, the supernatant was discarded, 20 μL and 200 μL DMSO of 5 mg / ml MTT reagent was added, and the absorbance at 570 nm was measured using a microplate reader after 3 hours to calculate the tumor cell proliferation inhibition rate of each group. The specific results are shown in Table 2, where:
增殖抑制率=(对照组吸光度值-实验组吸光度值)/对照组吸光度值×100%。Proliferation inhibition rate = (absorbance value of control group-absorbance value of experimental group) / absorbance value of control group × 100%.
2.3实验结果2.3 Experimental results
表2本发明药物组合物对肿瘤细胞的增殖抑制作用Table 2 Inhibitory effect of the pharmaceutical composition of the present invention on tumor cell proliferation
Figure PCTCN2019086298-appb-000002
Figure PCTCN2019086298-appb-000002
表2实验结果显示了鲨鱼软骨糖蛋白及本发明实施例5组药物组合物的提取物浸 膏针对于人皮肤癌细胞、人乳腺癌细胞、人肺腺癌细胞、人肝癌细胞和人胃癌细胞均显示了明显的增殖抑制作用,尤其是针对人皮肤癌细胞、人乳腺癌细胞、人肺腺癌细胞增殖抑制效果更为明显,表明了本发明药物组合物具有优异肿瘤细胞增殖抑制效果,而其他组成成分相同,但不含零陵香的对比例2组药物组合物针对于各肿瘤细胞的增殖抑制作用相对于实施例5组均明显降低,该实验结果也证明了零陵香的加入可明显提高含鲨鱼软骨的药物组合的抑制肿瘤细胞的增殖作用。Table 2 shows the results of the shark cartilage glycoprotein and the extract of the pharmaceutical composition of Example 5 of the present invention against human skin cancer cells, human breast cancer cells, human lung adenocarcinoma cells, human liver cancer cells, and human gastric cancer cells. All showed obvious proliferation inhibitory effects, especially against human skin cancer cells, human breast cancer cells, and human lung adenocarcinoma cell proliferation inhibition effects, indicating that the pharmaceutical composition of the present invention has excellent tumor cell proliferation inhibition effects, and Comparative group 2 of the same composition, but without tonka, has inhibitory effects on the proliferation of each tumor cell compared to the group of Example 5. The experimental results also prove that the addition of tonka can The combination of shark cartilage-containing drugs significantly inhibited tumor cell proliferation.
效果例3:本发明外敷膏剂对荷瘤小鼠的治疗效果Effect Example 3: Therapeutic effect of the external application cream of the present invention on tumor-bearing mice
3.1实验药物:3.1 Experimental drugs:
实施例4外敷膏剂。Example 4: External application cream.
3.2实验方法3.2 Experimental methods
雄性Balb/c小鼠20只,体重20±2g,适应性饲养1天后,酒精消毒小鼠前肢腋下,以5×10 4浓度接种小鼠黑色素瘤细胞B16 0.2mL,接种10天后挑选接种成功、且瘤体积大致相当的小鼠10只,随机分为2组,具体为模型组、实施例4组,每组5只,其中模型组使用生理盐水涂敷肿瘤部位,实施例4组将实施例4组制备得到的外敷膏剂涂敷于肿瘤部位,每天一次,涂敷完成后以纱布包裹涂敷部位,避免小鼠舔舐造成的涂敷物掉落,每次涂敷前清除上次涂敷的药渣,连续施用15天,末次给药2h后,记录各组存活小鼠只数,小鼠断颈处死,剥离肿瘤组织并称重,计算抑瘤率,具体实验见表3,其中: Male Balb / c mice 20 mice weighing 20 ± 2g, adaptive feeding for one day, mice forelimb armpit alcohol disinfectant to 5 × 10 4 cells were seeded at a concentration of mouse melanoma B16 0.2mL, successful inoculation 10 days after inoculation selection Ten mice with approximately the same tumor volume were randomly divided into two groups, specifically the model group and the group of Example 4, with five in each group, in which the model group was coated with the tumor site with physiological saline, and the group of Example 4 would be implemented The external dressing cream prepared in Example 4 was applied to the tumor site once a day. After the application was completed, the coated site was covered with gauze to prevent the coating material caused by the mouse from licking, and the previous application was removed before each application. The drug residue was continuously administered for 15 days, and the number of surviving mice in each group was recorded 2 hours after the last administration. The mice were sacrificed by neck dissection, the tumor tissue was stripped and weighed, and the tumor suppression rate was calculated. The specific experiment is shown in Table 3, where:
抑瘤率=(模型组瘤重-实验组瘤重)/模型组瘤重×100%。Tumor inhibition rate = (tumor weight in model group-tumor weight in experimental group) / tumor weight in model group × 100%.
3.3实验结果3.3 Experimental results
应用统计软件SPSS的多因素方差分析模块进行数据分析,P<0.05表示差异有统计学意义。Data analysis was performed using the multivariate analysis of variance module of statistical software SPSS. P <0.05 indicated that the difference was statistically significant.
表3实验结果显示了实验结束时模型组5只小鼠中已死亡两只,而实施例4组小鼠5只小鼠全部存活,荷瘤小鼠肿瘤的生长也受到了明显抑制,抑瘤率超过了50%,显示了优异的体内抗肿瘤效果。The experimental results in Table 3 show that two of the five mice in the model group have died at the end of the experiment, while all the five mice in the group of Example 4 survived. The tumor growth of the tumor-bearing mice was also significantly inhibited and the tumor was inhibited. The rate exceeded 50%, showing excellent antitumor effect in vivo.
表3本发明外敷膏剂对荷瘤小鼠的治疗效果Table 3 Therapeutic effect of the external application cream of the present invention on tumor-bearing mice
Figure PCTCN2019086298-appb-000003
Figure PCTCN2019086298-appb-000003
**,与模型组相比P<0.01。 ** , P <0.01 compared with the model group.
以上描述了本发明优选实施方式,然其并非用以限定本发明。本领域技术人员对在此公开的实施方案可进行并不偏离本发明范畴和精神的改进和变化。The preferred embodiments of the present invention have been described above, but they are not intended to limit the present invention. Those skilled in the art can make improvements and changes to the embodiments disclosed herein without departing from the scope and spirit of the invention.

Claims (10)

  1. 鲨鱼软骨糖蛋白在制备抗癌药物中的用途。Application of shark cartilage glycoprotein in preparing anticancer medicine.
  2. 根据权利要求1所述的用途,其特征在于所述鲨鱼软骨糖蛋白由以下方法制备得到:The use according to claim 1, characterized in that the shark cartilage glycoprotein is prepared by the following method:
    (1)鲨鱼软骨粉碎后过10-30目筛,的鲨鱼软骨颗粒;(1) Shark cartilage particles after shark cartilage crushed through a 10-30 mesh sieve;
    (2)鲨鱼软骨颗粒加入3-8倍的纯净水后使用NaOH调节pH为10-13,加热至50-70℃,浸泡3-10小时后过滤,滤液备用,滤渣重复浸提1-2次,滤液合并;(2) Shark cartilage granules are added with 3-8 times purified water, adjusted to pH 10-13 with NaOH, heated to 50-70 ° C, immersed for 3-10 hours and filtered, the filtrate is reserved, and the filter residue is repeatedly extracted 1-2 times The filtrates are combined;
    (3)滤液经盐析后,使用Sevage法去除游离蛋白质,再经透析和DEAE-C32阴离子交互树脂柱层析后制得。(3) After the filtrate is subjected to salting-out, the Sevage method is used to remove free proteins, and then the filtrate is obtained after dialysis and DEAE-C32 anion interaction resin column chromatography.
  3. 一种抗癌药物组合物,其特征在于包含鲨鱼软骨糖蛋白或鲨鱼软骨。An anticancer pharmaceutical composition, characterized in that it comprises shark cartilage glycoprotein or shark cartilage.
  4. 根据权利要求3所述的抗癌药物组合物,其特征在于还包含龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、山慈菇、败酱草、鱼腥草、黄芪、瞿麦、零陵香。The anticancer pharmaceutical composition according to claim 3, further comprising a turtle plate, abalone shell, baking soda, clam shell, portulaca oleracea, beef bone meal, Poria cocos, Shanci mushroom, sage grass, Houttuynia cordata , Astragalus, Qumai, Lingling.
  5. 根据权利要求4所述的抗癌药物组合物,其特征在于:所述药物组合物由鲨鱼软骨5-10份、龟板2-5份、鲍鱼壳1-3份、小苏打1-3份、蛤蜊壳1-3份、马齿苋3-8份、牛骨粉8-15份、土茯苓2-5份、山慈菇5-10份、败酱草2-5份、鱼腥草1-3份、黄芪1-3份、瞿麦1-3份、零陵香1-3份制成。The anticancer pharmaceutical composition according to claim 4, characterized in that the pharmaceutical composition comprises 5-10 parts of shark cartilage, 2-5 parts of turtle plate, 1-3 parts of abalone shell, 1-3 parts of baking soda, 1-3 shells of clam shells, 3-8 shells of purslane, 8-15 shells of beef bone powder, 2-5 shells of Poria cocos, 5-10 shells of Shanci mushrooms, 2-5 shells of misograss, 1-Houttuynia cordata Made from 3 servings, 1-3 servings of astragalus, 1-3 servings of qumai, and 1-3 servings of tonka.
  6. 根据权利要求5所述的抗癌药物组合物,其特征在于:所述药物组合物由鲨鱼骨80克、龟板30克、鲍鱼壳20克、小苏打20克、蛤蜊壳20克、马齿苋50克、牛骨粉100克、土茯苓30克、山慈菇80克、败酱草30克、鱼腥草10克、黄芪10克、瞿麦10克、零陵香10克制成。The anticancer pharmaceutical composition according to claim 5, characterized in that the pharmaceutical composition comprises 80 grams of shark bone, 30 grams of turtle plate, 20 grams of abalone shell, 20 grams of baking soda, 20 grams of clam shell, and purslane It is made of 50 grams, 100 grams of beef bone powder, 30 grams of Poria cocos, 80 grams of Shan Ci mushroom, 30 grams of spoiled grass, 10 grams of Houttuynia cordata, 10 grams of astragalus, 10 grams of qumai, and 10 grams of tonka.
  7. 权利要求4-6任一项所述的抗癌药物组合物,其特征在于:所述药物组合物为口服药物组合物或局部施用药物组合物。The anticancer pharmaceutical composition according to any one of claims 4 to 6, characterized in that the pharmaceutical composition is an oral pharmaceutical composition or a topical pharmaceutical composition.
  8. 根据权利要求7所述的抗癌药物组合物,其特征在于:所述口服药物组合物为片剂、胶囊剂、颗粒剂、丸剂、散剂、汤剂;所述局部施用药物组合物为外敷膏剂。The anticancer pharmaceutical composition according to claim 7, characterized in that: the oral pharmaceutical composition is a tablet, capsule, granule, pill, powder, decoction; and the topically applied pharmaceutical composition is an external plaster .
  9. 根据权利要求8所述的抗癌药物组合物,其特征在于:所述外敷膏剂通过以下方法制备得到:The anticancer pharmaceutical composition according to claim 8, characterized in that the external application cream is prepared by the following method:
    (1)将鲨鱼软骨、龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、山慈菇、败酱草、鱼腥草、黄芪、瞿麦、零陵香粉碎成150-200目颗粒;(1) Crush shark cartilage, tortoise shell, abalone shell, baking soda, clam shell, purslane, beef bone meal, earthy Poria, Shanci mushroom, sauerkraut, Houttuynia cordata, Astragalus, Qumai, Linglingxiang to 150 -200 mesh particles;
    (2)将鱼腥草、零陵香、山慈菇、败酱草颗粒使用海盐泡水48小时,使用时,使用该水将鲨鱼软骨、龟板、鲍鱼壳、小苏打、蛤蜊壳、马齿苋、牛骨粉、土茯苓、黄芪、瞿麦颗粒调成药膏,即得外敷膏剂。(2) Soak the water of Houttuynia cordatum, Tonka fragrant, Shanci mushroom, and rotten grass with sea salt for 48 hours. When using, use this water to shark cartilage, turtle plate, abalone shell, baking soda, clam shell, horse teeth Loquat, beef bone powder, Poria cocos, Astragalus and Qumai granules are prepared into ointments to obtain an external plaster.
  10. 权利要求4-9任一项所述的抗癌药物组合物在制备抗癌药物组合物中的用途。Use of the anticancer pharmaceutical composition according to any one of claims 4-9 in the preparation of an anticancer pharmaceutical composition.
PCT/CN2019/086298 2018-08-27 2019-05-09 Shark cartilage glycoprotein and anticancer use thereof WO2020042665A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810982435.9 2018-08-27
CN201810982435.9A CN108939043A (en) 2018-08-27 2018-08-27 A kind of Shark cartilage glycoprotein and its anticancer purpose

Publications (1)

Publication Number Publication Date
WO2020042665A1 true WO2020042665A1 (en) 2020-03-05

Family

ID=64473245

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/086298 WO2020042665A1 (en) 2018-08-27 2019-05-09 Shark cartilage glycoprotein and anticancer use thereof

Country Status (2)

Country Link
CN (1) CN108939043A (en)
WO (1) WO2020042665A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108939043A (en) * 2018-08-27 2018-12-07 车路平 A kind of Shark cartilage glycoprotein and its anticancer purpose
CN113116930A (en) * 2020-01-10 2021-07-16 姚明波 Anticancer medicine and its preparation method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423951A (en) * 2002-11-13 2004-11-16 Ming-Chung Wong Method of preparing anti-angiogenic drug from cartilage and chondrocytes and methods of use
CN101819181A (en) * 2010-04-09 2010-09-01 新疆三叶管道技术有限责任公司 Pipeline defect and magnetic leakage detection device
CN108939043A (en) * 2018-08-27 2018-12-07 车路平 A kind of Shark cartilage glycoprotein and its anticancer purpose

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200423951A (en) * 2002-11-13 2004-11-16 Ming-Chung Wong Method of preparing anti-angiogenic drug from cartilage and chondrocytes and methods of use
CN101819181A (en) * 2010-04-09 2010-09-01 新疆三叶管道技术有限责任公司 Pipeline defect and magnetic leakage detection device
CN108939043A (en) * 2018-08-27 2018-12-07 车路平 A kind of Shark cartilage glycoprotein and its anticancer purpose

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CAI, PING ET AL.: "Current Status of Research and Development of Shark Cartilage Angiogenesis Inhibitors", CHINESE JOURNAL OF MARINE DRUGS, 30 September 1996 (1996-09-30), pages 37 - 39 *
FANG, XUBO ET AL.: "Researches on Isolation, Purification and Identification of Chondroitin Sulfate-Glycoprotein from Sepia Illex Argentin", JOURNAL OF CHINESE INSTITUTE OF FOOD SCIENCE AND TECHNOLOGY, vol. 9, no. 4, 31 August 2009 (2009-08-31), pages 103 - 109 *
ZHENG, LANHONG ET AL.: "Research Progress on Shark Cartilage Angiogenesis Inhibitors at Home and Abroad", PROCEEDINGS OF2007 MEDICAL FRONTIER FORUM AND THE 10TH NATIONAL CONFERENCE OF CANCER PHARMACOLOGY AND CHEMOTHERAPY, 30 June 2007 (2007-06-30) *
ZHENG, LANHONG ET AL.: "Research Progress on Shark Cartilage Angiogenesis Inhibitors at Home and Abroad", PROCEEDINGS OF2007 MEDICAL FRONTIER FORUM AND THE 10TH NATIONAL CONFERENCE OF CANCER PHARMACOLOGY AND CHEMOTHERAPY, 30 June 2007 (2007-06-30), pages 205 *

Also Published As

Publication number Publication date
CN108939043A (en) 2018-12-07

Similar Documents

Publication Publication Date Title
WO2020042665A1 (en) Shark cartilage glycoprotein and anticancer use thereof
CN105878899A (en) Eatable drug having function of assisting treatment of gastric mucosal lesion and preparation method thereof
CN105535495B (en) A kind of Chinese medicine composition and preparation method of the element culturing fixed folder treatment cancer of the esophagus
CN112656925A (en) Medicinal and edible plant traditional Chinese medicine composition for preventing cancers
CN102940808A (en) Prescription medicine for treating lung cancer and preparation method
WO2018171672A1 (en) Anti-cancer pharmaceutical composition and use thereof
CN113368205A (en) Traditional Chinese medicine composition for treating gastric cancer
CN107095932A (en) It is a kind of to treat Chinese medicine ultramarine gypsum oral liquid of porcine hyperthermia and preparation method thereof
CN108186921B (en) An antitumor selenium-containing Chinese medicinal composition and its preparation method
CN105816753A (en) Preparation for eliminating phlegm and relieving cough
CN103735915B (en) A kind of medicine and preparation method for the treatment of esophageal carcinoma
CN103735997B (en) A kind of Chinese medicine preparation and preparation method for the treatment of gastric cancer
CN107854662A (en) A kind of Chinese medicine preparation for treating cirrhotic ascites and preparation method thereof
CN107468893A (en) A kind of pill medicine for treating habitual constipation and preparation method thereof
CN104984305B (en) A kind of Chinese medicine composition for treating chronic cholecystitis
CN112426491A (en) Traditional Chinese medicine composition for treating malignant melanoma
CN106668494A (en) Hui nationality traditional Chinese medicine astragalus membranaceus root stomach cancer-dispersing granules and preparation method thereof
CN105582439A (en) Traditional Chinese medicine composition for treating infantile malnutrition
CN105168907A (en) Traditional Chinese medicine for treating hyperplasia of mammary glands
CN112426500A (en) Traditional Chinese medicine composition for treating cervical cancer
CN109010704A (en) It is a kind of for controlling the Chinese medicine composition and preparation method of tumour growth
CN112426469A (en) Traditional Chinese medicine composition for treating ehrlich ascites carcinoma
CN110613744A (en) Traditional Chinese medicine composition for treating breast cancer liver metastasis and preparation method and application thereof
CN110227130A (en) A kind of Chinese medicine composition and preparation method thereof for treating breast cancer
CN106806461A (en) One kind treats recurrent oral ulceration navel paster

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19855874

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 02.06.2021)

122 Ep: pct application non-entry in european phase

Ref document number: 19855874

Country of ref document: EP

Kind code of ref document: A1